Literature DB >> 14520519

Monocyte chemoattractant protein (MCP)-1 production via functionally reconstituted Fcalpha receptor (CD89) on glomerular mesangial cells.

T Tsuge1, Y Suzuki, T Shimokawa, S Horikoshi, K Okumura, C Ra, Y Tomino.   

Abstract

BACKGROUND: Fc alpha receptor (FcalphaR; CD89) is the receptor for Fc portion of IgA in various cells, and displays various immunological responses on binding. It is important to analyze the mesangial functions via FcalphaR in the pathogenesis of IgA nephropathy. However, it is still controversial whether FcalphaR is expressed on mesangial cells. To assess biological functions of FcalphaR on the mesangial cells, we established mesangial transfectants that expressed FcalphaR with or without FcRgamma chain that is a common signaling molecule of FcRs. The production of monocyte chemoattractant protein-1 (MCP-1) by mesangial cells is known to contribute to cellular infiltration into glomeruli and subsequent glomerular injuries.
METHODS: Murine mesangial cell lines (SV40 MES 13) were transfected with cDNA of the human FcalphaR. Furthermore, we co-transfected some of the FcalphaR transfectants with cDNA of human FcRgamma chain. The tyrosine phosphorylation of the intra-mesangial proteins after FcalphaR cross-linking was examined by immunoprecipitation. MCP-1 production from each transfectant stimulated with heat aggregated IgA was determined by sandwich ELISA.
RESULTS: Two kinds of mesangial transfectants stably expressed human FcalphaR with or without FcRgamma chain (FcalphaR(+), FcalphaR(+)/gamma(+)). Phosphorylation of FcRgamma chain and syk kinase was detected in FcalphaR(+) and FcalphaR(+)/gamma(+) cells, but not in untransfected cells. Aggregated IgA induced significantly higher MCP-1 production in FcalphaR(+)/gamma(+) than those in FcalphaR(+) or untransfected control.
CONCLUSIONS: Present study demonstrated that FcalphaR and FcRgamma chain could be reconstituted in mesangial cells and mediated MCP-1 production by aggregated IgA in a dose-dependent manner. Current data would argue that FcalphaR can be activated in mesangial cells through their own machinery, although underlying mechanisms for FcalphaR induction in mesangial cells remain unclear.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520519     DOI: 10.1007/s00011-003-1200-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  7 in total

1.  Differential expression of spleen tyrosine kinase Syk isoforms in tissues: Effects of the microbial flora.

Authors:  Florentina Duta; Marina Ulanova; Daniel Seidel; Lakshmi Puttagunta; Sorin Musat-Marcu; Kevin S Harrod; Alan D Schreiber; Ulrich Steinhoff; A Dean Befus
Journal:  Histochem Cell Biol       Date:  2006-05-18       Impact factor: 4.304

2.  A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis.

Authors:  Jennifer Smith; John P McDaid; Gurjeet Bhangal; Ratana Chawanasuntorapoj; Esteban S Masuda; H Terence Cook; Charles D Pusey; Frederick W K Tam
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

3.  TREM-1 Contributes to Inflammation in IgA Nephropathy.

Authors:  Yan-Feng Zhao; Li Zhu; Li-Jun Liu; Su-Fang Shi; Ji-Cheng Lv; Hong Zhang
Journal:  Kidney Dis (Basel)       Date:  2018-01-12

Review 4.  Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy.

Authors:  Stephen McAdoo; Frederick W K Tam
Journal:  Semin Nephrol       Date:  2018-09       Impact factor: 5.299

5.  Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy.

Authors:  Wai Han Yiu; Kam Wa Chan; Loretta Y Y Chan; Joseph C K Leung; Kar Neng Lai; Sydney C W Tang
Journal:  Front Physiol       Date:  2021-03-15       Impact factor: 4.566

6.  Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathy.

Authors:  Masashi Aizawa; Yusuke Suzuki; Hitoshi Suzuki; Huihua Pang; Masao Kihara; Junichiro Nakata; Kenji Yamaji; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

7.  Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.

Authors:  Yan-Feng Zhao; Li Zhu; Li-Jun Liu; Su-Fang Shi; Ji-Cheng Lv; Hong Zhang
Journal:  BMC Nephrol       Date:  2017-09-29       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.